Eluvixtamab (AMG-330)

From HemOnc.org - A Hematology Oncology Wiki

Revision as of 17:44, 3 February 2019 by Warner-admin (talk | contribs) (Text replacement - "Category:Investigational" to "Category:Investigational drugs")

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to navigation Jump to search

Mechanism of action

Bispecific T-cell engager (BiTE) antibody that engages CD33 and CD3

Retrieved from "https://hemonc.org/w/index.php?title=Eluvixtamab_(AMG-330)&oldid=35420"